415 related articles for article (PubMed ID: 33610693)
1. Adaptive immune responses to SARS-CoV-2.
Forthal D
Adv Drug Deliv Rev; 2021 May; 172():1-8. PubMed ID: 33610693
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive adaptive immunity against coronaviruses in young children.
Nat Immunol; 2022 Jan; 23(1):11-12. PubMed ID: 34937929
[No Abstract] [Full Text] [Related]
3. mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2.
Hassert M; Geerling E; Stone ET; Steffen TL; Feldman MS; Dickson AL; Class J; Richner JM; Brien JD; Pinto AK
PLoS Pathog; 2020 Dec; 16(12):e1009163. PubMed ID: 33326500
[TBL] [Abstract][Full Text] [Related]
4. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
Front Immunol; 2021; 12():797919. PubMed ID: 34975908
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
[TBL] [Abstract][Full Text] [Related]
6. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
Front Immunol; 2020; 11():610300. PubMed ID: 33391280
[TBL] [Abstract][Full Text] [Related]
7. Immune profiling of COVID-19: preliminary findings and implications for the pandemic.
Maecker HT
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963016
[TBL] [Abstract][Full Text] [Related]
8. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
Uraki R; Imai M; Ito M; Shime H; Odanaka M; Okuda M; Kawaoka Y; Yamazaki S
PLoS Pathog; 2021 Dec; 17(12):e1010085. PubMed ID: 34882757
[TBL] [Abstract][Full Text] [Related]
9. Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
Fong SW; Yeo NK; Chan YH; Goh YS; Amrun SN; Ang N; Rajapakse MP; Lum J; Foo S; Lee CY; Carissimo G; Chee RS; Torres-Ruesta A; Tay MZ; Chang ZW; Poh CM; Young BE; Tambyah PA; Kalimuddin S; Leo YS; Lye DC; Lee B; Biswas S; Howland SW; Renia L; Ng LFP
J Clin Immunol; 2022 Feb; 42(2):214-229. PubMed ID: 34716845
[TBL] [Abstract][Full Text] [Related]
10. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
Lotfi R; Kalmarzi RN; Roghani SA
Immunol Res; 2021 Jun; 69(3):213-224. PubMed ID: 33928531
[TBL] [Abstract][Full Text] [Related]
11. Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.
Mohn KG; Bredholt G; Zhou F; Madsen A; Onyango TB; Fjelltveit EB; Jalloh SL; Brokstad KA; Cantoni D; Mayora-Neto M; Temperton N; Langeland N; Cox RJ;
PLoS One; 2022; 17(2):e0261979. PubMed ID: 35192617
[TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive immune responses against coronavirus.
Hosseini A; Hashemi V; Shomali N; Asghari F; Gharibi T; Akbari M; Gholizadeh S; Jafari A
Biomed Pharmacother; 2020 Dec; 132():110859. PubMed ID: 33120236
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.
Sen K; Datta S; Ghosh A; Jha A; Ahad A; Chatterjee S; Suranjika S; Sengupta S; Bhattacharya G; Shriwas O; Avula K; Kshatri J; Prasad P; Swain R; Parida AK; Raghav SK
Front Immunol; 2021; 12():733539. PubMed ID: 34899693
[TBL] [Abstract][Full Text] [Related]
14. T-cell responses and therapies against SARS-CoV-2 infection.
Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Yatim N; Boussier J; Tetu P; Smith N; Bruel T; Charbit B; Barnabei L; Corneau A; Da Meda L; Allayous C; Baroudjian B; Jebali M; Herms F; Grzelak L; Staropoli I; Calmettes V; Hadjadj J; Peyrony O; Cassius C; LeGoff J; Kramkimel N; Aractingi S; Fontes M; Blanc C; Rieux-Laucat F; Schwartz O; Terrier B; Duffy D; Lebbé C
Sci Adv; 2021 Aug; 7(34):. PubMed ID: 34407944
[TBL] [Abstract][Full Text] [Related]
16. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Boechat JL; Chora I; Morais A; Delgado L
Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
[TBL] [Abstract][Full Text] [Related]
17. T Cells: Warriors of SARS-CoV-2 Infection.
de Candia P; Prattichizzo F; Garavelli S; Matarese G
Trends Immunol; 2021 Jan; 42(1):18-30. PubMed ID: 33277181
[TBL] [Abstract][Full Text] [Related]
18. Biological Significance of Anti-SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy.
Manouchehri N; Steinman L; Stuve O
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33361386
[TBL] [Abstract][Full Text] [Related]
19. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
O'Connell P; Aldhamen YA
Hum Vaccin Immunother; 2020 Dec; 16(12):2980-2991. PubMed ID: 32878546
[TBL] [Abstract][Full Text] [Related]
20. A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections.
Alamri A; Fisk D; Upreti D; Kung SKP
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
